1. Sousa N, Fautino C, Aguas LMN, Freire J, Coutinho C, Fautino I, Capela A, Costa T, Costa ASA, Coelho S, Pereira F, Abreu SC, Rolo AS, Albergaria A, Lima J, Wen XG, Mesquita C, Dias CC, Azevedo LF, Carneiro F

Homologous recombination deficiency as prognostic marker in metastatic gastric cancer. Journal of Clinical Oncology 37: ., 2019.  [Meeting Abstract] 

 doi: 10.1200/JCO.2019.37.15_suppl.4040.

 

2. Ferreira AM, Westers H, Albergaria A, Seruca R, Hofstra RM

Estrogen, MSI and Lynch syndrome-associated tumours Biochimica et Biophysica acta-Reviews on Cancer 0: 0, 2009.  [Review] 

 PMID: 19559756.

 

3. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Simões-Correia J, Oliveira MJ, Pinheiro H, Pinho SS, Mateus R, Reis CA, Leite M, Fernandes MS, Schmitt F, Carneiro F, Figueiredo C, Oliveira C, Seruca R

Epithelial E- and P-cadherins: Role and clinical significance in cancer. Biochimica et Biophysica acta-Reviews on Cancer 1826: 297-311, 2012.  [Review] 

 doi: 10.1016/j.bbcan.2012.05.002 PMID: 22613680.

 

4. Albergaria A, Ribeiro AS, Pinho S, Milanezi F, Carneiro V, Sousa B, Sousa S, Oliveira C, Machado JC, Seruca R, Paredes J, Schmitt F

ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation. Human molecular genetics 19: 2554-66, 2010.  [Article] 

 doi: 10.1093/hmg/ddq134 PMID: 20385540.

 

5. Pereira MS, Maia L, Azevedo LF, Campos S, Carvalho S, Dias AM, Albergaria A, Lima J, Marcos-Pinto R, Lago P, Pinho SS

A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis Patients. Journal of Crohn's & colitis 13: 39-49, 2019.  [Article] 

 doi: 10.1093/ecco-jcc/jjy139 PMID: 30239648.

 

6. Vieira AF, Ricardo S, Ablett MP, Dionísio MR, Mendes N, Albergaria A, Farnie G, Gerhard R, Cameselle-Teijeiro JF, Seruca R, Schmitt F, Clarke RB, Paredes J

P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer. Stem cells (Dayton, Ohio) 30: 854-64, 2012.  [Article] 

 doi: 10.1002/stem.1075 PMID: 22389315.

 

7. Ribeiro AS, Albergaria A, Sousa B, Correia AL, Bracke M, Seruca R, Schmitt FC, Paredes J

Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene 29: 392-402, 2010.  [Article] 

 doi: 10.1038/onc.2009.338 PMID: 19901964.

 

8. Ribeiro AS, Sousa B, Carreto L, Mendes N, Nobre AR, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Söderberg O, Seruca R, Santos MA, Schmitt F, Paredes J

P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model. The Journal of pathology 229: 705-18, 2013.  [Article] 

 doi: 10.1002/path.4143 PMID: 23180380.

 

9. Goto T, Takano M, Albergaria A, Briese J, Pomeranz KM, Cloke B, Fusi L, Feroze-Zaidi F, Maywald N, Sajin M, Dina RE, Ishihara O, Takeda S, Lam EW, Bamberger AM, Ghaem-Maghami S, Brosens JJ

Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells. Oncogene 27: 9-19, 2008.  [Article] 

 doi: 10.1038/sj.onc.1210626 PMID: 17599040.

 

10. Vieira AF, Ribeiro AS, Dionísio MR, Sousa B, Nobre AR, Albergaria A, Santiago-Gómez A, Mendes N, Gerhard R, Schmitt F, Clarke RB, Paredes J

P-cadherin signals through the laminin receptor a6ß4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells. Oncotarget 5: 679-92, 2014.  [Article] 

 PMID: 24553076.

 

11. Paredes J, Albergaria A, Oliveira JT, Jerónimo C, Milanezi F, Schmitt FC

P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clinical cancer research : an official journal of the American Association for Cancer Research 11: 5869-77, 2005.  [Article] 

 doi: 10.1158/1078-0432.CCR-05-0059 PMID: 16115928.

 

12. Ribeiro AS, Sousa B, Carreto L, Mendes N, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Soderberg O, Seruca R, Santos MA, Schmitt F, Paredes J

P-cadherin promotes cancer cell invasion by interference with E-cadherin suppressor function The FASEB Journal  1, 2011.  [] 

.

 

13. Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, Lunet N, Schmitt F

Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast cancer research : BCR 11: 3, 2009.  [Article] 

 PMID: 19549328.

 

14. Krol J, Francis RE, Albergaria A, Sunters A, Polychronis A, Coombes RC, Lam EW

The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells. Molecular cancer therapeutics 6: 3169-79, 2007.  [Article] 

 doi: 10.1158/1535-7163.MCT-07-0507 PMID: 18089711.

 

15. Paredes J, Correia AL, Ribeiro AS, Albergaria A, Milanezi F, Schmitt FC

P-cadherin expression in breast cancer: a review. Breast cancer research : BCR 9: 214, 2007.  [Review] 

 doi: 10.1186/bcr1774 PMID: 18001487.

 

16. Pinheiro C, Albergaria A, Paredes J, Sousa B, Dufloth R, Vieira D, Schmitt F, Baltazar F

Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 56: 860-7, 2010.  [Article] 

 doi: 10.1111/j.1365-2559.2010.03560.x PMID: 20636790.

 

17. Albergaria A, Resende C, Nobre AR, Ribeiro AS, Sousa B, Machado JC, Seruca R, Paredes J, Schmitt F

CCAAT/enhancer binding protein ß (C/EBPß) isoforms as transcriptional regulators of the pro-invasive CDH3/P-cadherin gene in human breast cancer cells. PloS one 8: e55749, 2013.  [Article] 

 doi: 10.1371/journal.pone.0055749 PMID: 23405208.

 

18. Sousa B, Ribeiro AS, Nobre AR, Lopes N, Martins D, Pinheiro C, Vieira AF, Albergaria A, Gerhard R, Schmitt F, Baltazar F, Paredes J

The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype. BMC cancer 14: 734, 2014.  [Article] 

 doi: 10.1186/1471-2407-14-734 PMID: 25269858.

 

19. Albergaria A, Ricardo S, Milanezi F, Carneiro V, Amendoeira I, Vieira D, Cameselle-Teijeiro J, Schmitt F

Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool? BMC cancer 11: 299, 2011.  [Article] 

 doi: 10.1186/1471-2407-11-299 PMID: 21762477.

 

20. Martins D, Sousa B, Lopes N, Gomes M, Veronese L, Albergaria A, Paredes J, Schmitt F

Molecular phenotypes of matched in situ and invasive components of breast carcinomas. Human pathology 42: 1438-46, 2011.  [Article] 

 doi: 10.1016/j.humpath.2010.08.024 PMID: 21450330.

 

21. Albergaria A, Ribeiro A S, Vieira AF, Sousa B, Nobre AR, Seruca R, Schmitt F, Paredes J

P-cadherin role in normal breast development and cancer. International Journal Dev Biology  811-822, 2011.  [Article] 

 doi: 10.1387/ijdb.113382aa.

 

22. Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC

p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast. Journal of clinical pathology 55: 936-9, 2002.  [Article] 

 PMID: 12461063.

 

23. Sousa B, Paredes J, Milanezi F, Lopes N, Martins D, Dufloth R, Vieira D, Albergaria A, Veronese L, Carneiro V, Carvalho S, Costa JL, Zeferino L, Schmitt F

P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study. Histology and histopathology 25: 963-74, 2010.  [Article] 

 PMID: 20552547.

 

24. Gerhard R, Ricardo S, Albergaria A, Gomes M, Silva AR, Logullo AF, Cameselle-Teijeiro JF, Paredes J, Schmitt F

Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas. Breast (Edinburgh, Scotland) 21: 354-60, 2012.  [Article] 

 doi: 10.1016/j.breast.2012.03.001 PMID: 22464177.

 

25. Pinheiro C, Sousa B, Albergaria A, Paredes J, Dufloth R, Vieira D, Schmitt F, Baltazar F

GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Histology and histopathology 26: 1279-86, 2011.  [Article] 

 PMID: 21870331.

 

26. Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC

Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples. Cancer 99: 172-9, 2003.  [Article] 

 doi: 10.1002/cncr.11061 PMID: 12811858.

 

27. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC

Maspin expression in normal skin and usual cutaneous carcinomas. Virchows Archiv : an international journal of pathology 441: 551-8, 2002.  [Article] 

 doi: 10.1007/s00428-002-0710-1 PMID: 12461611.

 

28. Nobre AR, Albergaria A, Schmitt F

p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63. Acta cytologica 57: 1-8, 2013.  [Review] 

 doi: 10.1159/000345245 PMID: 23221041.

 

29. Gerhard R, Carvalho A, Carneiro V, Bento RS, Uemura G, Gomes M, Albergaria A, Schmitt F

Clinicopathological significance of ERCC1 expression in breast cancer. Pathology, research and practice 209: 331-6, 2013.  [Article] 

 doi: 10.1016/j.prp.2013.02.009 PMID: 23702380.

 

30. Gama A, Paredes J, Albergaria A, Gartner F, Schmitt F

P-cadherin expression in canine mammary tissues. Journal of comparative pathology 130: 13-20, 2004.  [Article] 

 PMID: 14693120.

 

31. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC

p63 expression in normal skin and usual cutaneous carcinomas. Journal of cutaneous pathology 29: 517-23, 2002.  [Article] 

 PMID: 12358808.

 

32. Reis-Filho JS, Albergaria A, Milanezi F, Amendoeira I, Schmitt FC

Naked nuclei revisited: p63 Immunoexpression. Diagnostic cytopathology 27: 135-8, 2002.  [Article] 

 doi: 10.1002/dc.10164 PMID: 12203858.

 

33. Longatto Filho A, Albergaria A, Paredes J, Moreira MA, Milanezi F, Schmitt FC

P-cadherin expression in glandular lesions of the uterine cervix detected by liquid-based cytology. Cytopathology : official journal of the British Society for Clinical Cytology 16: 88-93, 2005.  [Article] 

 doi: 10.1111/j.1365-2303.2004.00226.x PMID: 15787651.

 

34. Paredes J, Albergaria A, Carvalho S, Schmitt F

"Basal-like" breast cancer carcinomas: Identification by P-cadherin, p63, EGFR and basal cytokeratins expression. Applied Cancer Research 26: 41-55, 2006.  [] 

.